171 related articles for article (PubMed ID: 23466634)
1. Cytochrome P450 epoxygenase metabolite, 14,15-EET, protects against isoproterenol-induced cellular hypertrophy in H9c2 rat cell line.
Tse MM; Aboutabl ME; Althurwi HN; Elshenawy OH; Abdelhamid G; El-Kadi AO
Vascul Pharmacol; 2013; 58(5-6):363-73. PubMed ID: 23466634
[TBL] [Abstract][Full Text] [Related]
2. Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy.
Althurwi HN; Tse MM; Abdelhamid G; Zordoky BN; Hammock BD; El-Kadi AO
Br J Pharmacol; 2013 Apr; 168(8):1794-807. PubMed ID: 23176298
[TBL] [Abstract][Full Text] [Related]
3. Early Changes in Cytochrome P450s and Their Associated Arachidonic Acid Metabolites Play a Crucial Role in the Initiation of Cardiac Hypertrophy Induced by Isoproterenol.
Althurwi HN; Maayah ZH; Elshenawy OH; El-Kadi AO
Drug Metab Dispos; 2015 Aug; 43(8):1254-66. PubMed ID: 26033621
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats.
Zordoky BN; Aboutabl ME; El-Kadi AO
Drug Metab Dispos; 2008 Nov; 36(11):2277-86. PubMed ID: 18725507
[TBL] [Abstract][Full Text] [Related]
5. Fenofibrate modulates cytochrome P450 and arachidonic acid metabolism in the heart and protects against isoproterenol-induced cardiac hypertrophy.
Althurwi HN; Elshenawy OH; El-Kadi AO
J Cardiovasc Pharmacol; 2014 Feb; 63(2):167-77. PubMed ID: 24157956
[TBL] [Abstract][Full Text] [Related]
6. The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol.
Maayah ZH; Althurwi HN; El-Sherbeni AA; Abdelhamid G; Siraki AG; El-Kadi AO
Mol Cell Biochem; 2017 May; 429(1-2):151-165. PubMed ID: 28251434
[TBL] [Abstract][Full Text] [Related]
7. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart.
Amara IE; Elshenawy OH; Abdelrady M; El-Kadi AO
Toxicol Lett; 2014 Apr; 226(1):53-62. PubMed ID: 24472606
[TBL] [Abstract][Full Text] [Related]
8. Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats.
Zordoky BN; Anwar-Mohamed A; Aboutabl ME; El-Kadi AO
Toxicol Appl Pharmacol; 2010 Jan; 242(1):38-46. PubMed ID: 19796650
[TBL] [Abstract][Full Text] [Related]
9. Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells.
Katragadda D; Batchu SN; Cho WJ; Chaudhary KR; Falck JR; Seubert JM
J Mol Cell Cardiol; 2009 Jun; 46(6):867-75. PubMed ID: 19285984
[TBL] [Abstract][Full Text] [Related]
10. Development of cellular hypertrophy by 8-hydroxyeicosatetraenoic acid in the human ventricular cardiomyocyte, RL-14 cell line, is implicated by MAPK and NF-κB.
Maayah ZH; Abdelhamid G; El-Kadi AO
Cell Biol Toxicol; 2015 Oct; 31(4-5):241-59. PubMed ID: 26493311
[TBL] [Abstract][Full Text] [Related]
11. The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity.
Maayah ZH; Abdelhamid G; Elshenawy OH; El-Sherbeni AA; Althurwi HN; McGinn E; Dawood D; Alammari AH; El-Kadi AOS
Cardiovasc Toxicol; 2018 Jun; 18(3):268-283. PubMed ID: 29196978
[TBL] [Abstract][Full Text] [Related]
12. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and beta-naphthoflavone induce cellular hypertrophy in H9c2 cells by an aryl hydrocarbon receptor-dependant mechanism.
Zordoky BN; El-Kadi AO
Toxicol In Vitro; 2010 Apr; 24(3):863-71. PubMed ID: 19969063
[TBL] [Abstract][Full Text] [Related]
13. Chronic doxorubicin cardiotoxicity modulates cardiac cytochrome P450-mediated arachidonic acid metabolism in rats.
Alsaad AM; Zordoky BN; El-Sherbeni AA; El-Kadi AO
Drug Metab Dispos; 2012 Nov; 40(11):2126-35. PubMed ID: 22867862
[TBL] [Abstract][Full Text] [Related]
14.
Shoieb SM; El-Kadi AOS
Drug Metab Dispos; 2018 Aug; 46(8):1157-1168. PubMed ID: 29880629
[TBL] [Abstract][Full Text] [Related]
15. Induction of several cytochrome P450 genes by doxorubicin in H9c2 cells.
Zordoky BN; El-Kadi AO
Vascul Pharmacol; 2008; 49(4-6):166-72. PubMed ID: 18707023
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of soluble epoxide hydrolase confers cardioprotection and prevents cardiac cytochrome P450 induction by benzo(a)pyrene.
Aboutabl ME; Zordoky BN; Hammock BD; El-Kadi AO
J Cardiovasc Pharmacol; 2011 Mar; 57(3):273-81. PubMed ID: 21383588
[TBL] [Abstract][Full Text] [Related]
17. Dasatinib induces gene expression of CYP1A1, CYP1B1, and cardiac hypertrophy markers (BNP, β-MHC) in rat cardiomyocyte H9c2 cells.
Alsaad AMS
Toxicol Mech Methods; 2018 Nov; 28(9):678-684. PubMed ID: 29975149
[TBL] [Abstract][Full Text] [Related]
18. Soluble epoxide hydrolase inhibitor, TUPS, attenuates isoproterenol/angiotensin II-induced cardiac hypertrophy through mammalian target of rapamycin-mediated autophagy inhibition.
Zhang H; Zhang K; Liang J; Yan W; Wu F; Xu W; Wu Z; Chen Y; Pan R; Wu G
J Pharm Pharmacol; 2019 Aug; 71(8):1291-1300. PubMed ID: 31215026
[TBL] [Abstract][Full Text] [Related]
19. Acute arsenic toxicity alters cytochrome P450 and soluble epoxide hydrolase and their associated arachidonic acid metabolism in C57Bl/6 mouse heart.
Anwar-Mohamed A; El-Sherbeni AA; Kim SH; Althurwi HN; Zordoky BN; El-Kadi AO
Xenobiotica; 2012 Dec; 42(12):1235-47. PubMed ID: 22680237
[TBL] [Abstract][Full Text] [Related]
20. 19-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy.
Elkhatali S; El-Sherbeni AA; Elshenawy OH; Abdelhamid G; El-Kadi AO
Toxicol Appl Pharmacol; 2015 Dec; 289(3):550-9. PubMed ID: 26454030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
